Healthcare -
Biotechnology - NASDAQ - US
$ 7.2
-2.3 %
$ 6 M
Market Cap
-0.01
P/E
RNAZ - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RNAZ - TransCode Therapeutics, Inc.
16.4 M
LAST VALUE
5133.12%
2 YEAR CAGR
100.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR